company background image
HKMP.Y logo

Hikma Pharmaceuticals OTCPK:HKMP.Y Stock Report

Last Price

US$52.33

Market Cap

US$5.8b

7D

-5.6%

1Y

9.4%

Updated

14 Mar, 2025

Data

Company Financials +

Hikma Pharmaceuticals PLC

OTCPK:HKMP.Y Stock Report

Market Cap: US$5.8b

HKMP.Y Stock Overview

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. More details

HKMP.Y fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance4/6
Financial Health4/6
Dividends5/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Hikma Pharmaceuticals PLC Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hikma Pharmaceuticals
Historical stock prices
Current Share PriceUK£52.33
52 Week HighUK£59.26
52 Week LowUK£46.16
Beta0.45
1 Month Change-10.97%
3 Month Change7.12%
1 Year Change9.39%
3 Year Change-7.27%
5 Year Change16.01%
Change since IPO115.53%

Recent News & Updates

Recent updates

Shareholder Returns

HKMP.YUS PharmaceuticalsUS Market
7D-5.6%-3.9%-2.2%
1Y9.4%-0.07%9.5%

Return vs Industry: HKMP.Y exceeded the US Pharmaceuticals industry which returned -0.8% over the past year.

Return vs Market: HKMP.Y exceeded the US Market which returned 6.6% over the past year.

Price Volatility

Is HKMP.Y's price volatile compared to industry and market?
HKMP.Y volatility
HKMP.Y Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement10.3%
Market Average Movement6.4%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market3.4%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine HKMP.Y's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19789,500Riad Mishlawiwww.hikma.com

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

Hikma Pharmaceuticals PLC Fundamentals Summary

How do Hikma Pharmaceuticals's earnings and revenue compare to its market cap?
HKMP.Y fundamental statistics
Market capUS$5.77b
Earnings (TTM)US$359.00m
Revenue (TTM)US$3.13b

16.1x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HKMP.Y income statement (TTM)
RevenueUS$3.13b
Cost of RevenueUS$1.71b
Gross ProfitUS$1.42b
Other ExpensesUS$1.06b
EarningsUS$359.00m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 07, 2025

Earnings per share (EPS)1.62
Gross Margin45.25%
Net Profit Margin11.48%
Debt/Equity Ratio53.8%

How did HKMP.Y perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

49%

Payout Ratio

Does HKMP.Y pay a reliable dividends?

See HKMP.Y dividend history and benchmarks
When do you need to buy HKMP.Y by to receive an upcoming dividend?
Hikma Pharmaceuticals dividend dates
Ex Dividend DateMar 21 2025
Dividend Pay DateMay 12 2025
Days until Ex dividend5 days
Days until Dividend pay date57 days

Does HKMP.Y pay a reliable dividends?

See HKMP.Y dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 23:35
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hikma Pharmaceuticals PLC is covered by 37 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
Emily FieldBarclays
Simon MatherBarclays